The Community Guide

- gsearch

Search Results

Narrow Results:

2019 1
2017 1
2013 1
2011 1

Botswana 3

Journal Article 4

1 - 4 of 4 Results

Refine Results

Refine Results:

Clinical Trial in Botswana

CITE Title : Clinical Trial in Botswana Personal Author(s) : Gust, Deborah A.;Mosimaneotsile, Barudi;Mathebula, Unami;Chingapane, Balladiah;Gaul, Zaneta;Pals, Sherri L.;Samandari, Taraz; Published Date : Apr 25 2011 Source : PLoS One. 6(4). URL : https://stacks.cdc.gov/view/cdc/4317 Gust, Deborah A. et al. (2011). Clinical Trial in Botswana. 6(4). Gust, Deborah A. et al. "Clinical Trial in Botswana" 6, no. 4 (2011) Gust, Deborah A. et al. "Clinical Trial in Botswana" vol. 6, no. 4, 2011 Export RIS Citation Information.

:

Gust, Deborah A. ;

Mosimaneotsile, Barudi

Apr 25 2011 | PLoS One. 6(4).

:

BackgroundParticipant non-adherence and loss to follow-up can compromise the validity of clinical trial results. An assessment of these issues was mad...
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay

CITE Title : Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay Personal Author(s) : Agizew, Tefera;Basotli, Joyce;Alexander, Heather;Boyd, Rosanna;Letsibogo, Gaoraelwe;Auld, Andrew;Nyirenda, Sambayawo;Tedla, Zegabriel;Mathoma, Anikie;Mathebula, Unami;Pals, Sherri;Date, Anand;Finlay, Alyssa; Published Date : Dec 22 2017 Source : PLoS One. 12(12). URL : https://stacks.cdc.gov/view/cdc/61214 Agizew, Tefera et al. (2017). Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay. 12(12). Agizew, Tefera et al. "Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay" 12, no. 12 (2017) Agizew, Tefera et al. "Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay" vol. 12, no. 12, 2017 Export RIS Citation Information.

:

Agizew, Tefera ;

Basotli, Joyce

Dec 22 2017 | PLoS One. 12(12).

:

BackgroundNon-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM...
The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear

CITE Title : The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear Personal Author(s) : Zimba, Onani;Tamuhla, Tsaone;Basotli, Joyce;Letsibogo, Gaoraelwe;Pals, Sherri;Mathebula, Unami;Mathoma, Anikie;Serumola, Christopher;Ramogale, Kitso;Boyd, Rosanna;Tran, Tiffany;Finlay, Alyssa;Auld, Andrew;Date, Anand;Alexander, Heather;Chihota, Violet;Agizew, Tefera; Published Date : June 13 2019 Source : Pan Afr Med J. 2019; 33 URL : https://stacks.cdc.gov/view/cdc/82539 Zimba, Onani et al. (2019). The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear. 33 Zimba, Onani et al. "The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear" 33 (2019) Zimba, Onani et al. "The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear" vol. 33, 2019 Export RIS Citation Information.

:

Zimba, Onani ;

Tamuhla, Tsaone

June 13 2019 | Pan Afr Med J. 2019; 33

:

IntroductionThe World Health Organization endorsed (2010) the use of Xpert MTB/RIF and countries are shifting from smear microscopy (smear)-based to X...
Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy

CITE Title : Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy Personal Author(s) : Taylor, Allan W.;Mosimaneotsile, Barudi;Mathebula, Unami;Mathoma, Anikie;Moathlodi, Ritah;Theebetsile, Irene;Samandari, Taraz; Published Date : Mar 07 2013 Source : Infect Dis Obstet Gynecol. 2013; 2013. URL : https://stacks.cdc.gov/view/cdc/13268 Taylor, Allan W. et al. (2013). Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy. 2013 Taylor, Allan W. et al. "Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy" 2013 (2013) Taylor, Allan W. et al. "Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy" vol. 2013, 2013 Export RIS Citation Information.

:

Taylor, Allan W. ;

Mosimaneotsile, Barudi

Mar 07 2013 | Infect Dis Obstet Gynecol. 2013; 2013.

:

While 6- to 12-month courses of isoniazid for tuberculosis prevention are considered safe in pregnant women, the effects of longer-term isoniazid prop...